Sarcoidosis: Yet another masquerader the cardiologist / electrophysiologist has to fight withdP in patients with complete atrioventricular block

Indian Pacing and Electrophysiology Journal

Volumn 10, Issue 11, 2010, Pages 479-485

  Menon, Syamkumar M Divakara ^a   Chemello, Diego ^a   Morillo, Carlos A ^a  

^a HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

Arrhythmias; Sarcoidosis

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; FLUORODEOXYGLUCOSE F 18; HYDROXYCHLOROQUINE; INFLIXIMAB;

ACUTE CORONARY SYNDROME; ATRIOVENTRICULAR CONDUCTION; CARDIOLOGIST; CLINICAL FEATURE; COMPLETE HEART BLOCK; CONGESTIVE HEART FAILURE; DISEASE ASSOCIATION; DISEASE COURSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; ECG ABNORMALITY; EDITORIAL; ELECTROCARDIOGRAPHY; GRANULOMA; HEART BLOCK; HEART DEATH; HEART ELECTROPHYSIOLOGY; HEART FAILURE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE BIOPSY; HEART VENTRICLE ANEURYSM; HEART VENTRICLE ARRHYTHMIA; HOLTER MONITORING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERMETHOD COMPARISON; LOW DRUG DOSE; MITRAL VALVE REGURGITATION; MORTALITY; MYCOBACTERIOSIS; MYOCARDIAL PERFUSION IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATHOPHYSIOLOGY; PERICARDITIS; POLLEN; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PROGNOSIS; PROPIONIBACTERIUM; RECURRENT DISEASE; RESPIRATORY FAILURE; RISK ASSESSMENT; RISK FACTOR; SARCOIDOSIS; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TRICUSPID VALVE REGURGITATION;

EID: 78650801504     PISSN: None     EISSN: 09726292     Source Type: Journal    
DOI: None     Document Type: Editorial

References (45)

1. James DG. Descriptive definition and historic aspects of sarcoidosis. Clin Chest Med. 1997;18;663-679
2. Eishi Y, Suga M,ishige I,et al.Quantitative analysis of Mycobacterial and ropionibacterial DNA in lymph nodes of Japanese and Euopean patients with sarcoidosis. J Clin Microbiol.2002;40:198-204
3. Rybicki BA, Ahmed KL, Maliarik MJ et al. Photocopier exposure and sisk of sarcoidosis in African American sibs. Sarcoidosis Vasc Diffuse Lung Dis. 2004;21:49-55.
4. Kucera GP, Rybicki BA, Kirkey KL,et al. Occupational risk factors for sarcoidosis in African American Siblings. Chest 1999;116:1183-1193.
5. Aubrat F, Diebold B, Dhote R, et al. Cardiac sarcoidosis. Rev Mal Respir 2003;20:S45-S49.
6. Kim JS, Judson MA, Donnino R rt al. Cardiac sarcoidosis. Am Heart J 2009;157:9-21.
7. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid:a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978;58:1204-1211.
8. Iwai K, Sekiguti M, Hosoda Y etal. Racial difference in cardiac sarcoidosis observed in autopsy. Sarcoidosis 1994; 11:26-31.
9. Matsui Y, Iwai K, Tachibana T, et al. Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci 1976;278:455-569
10. Roberts WC, McAllister HA Jr, Ferrans VJ. Sarcoidosis of the heart:a clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (Group II). Am J Med 1977;63:86-108.
11. Flemming H A, Bailey S M. Sarcoid heart disease. J R Coll Physicians Lond 1981; 15; 245-246;249-253
12. Uijlings R, Balt J C, Boom P, Wever E. et al. Cardiac sarcoidosis mimicking non ST elevation myocardial infarction. J Cardiovasc Med (Hagerstown). 2010. [Epub ahead of print]
13. Wyplosz B, Marijon E, Dougados J et al. Sarcoidosis: an unsual cause of acute pericarditis. Acta Cardiol. 2010;65:83-4.
14. Suzuki T, Kanda T, Kubota S et al. Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest 1994;106:1021-1024
15. Mehta D, Lubitz SA, Frankel Z et al. Cardiac Involvement in patients with sarcoidosis:Diagnostic and prognostic value in outpatient testing. Chest 2008;133:1426-1435
16. Aizer A, Stem EH, Gomes JA et al. Usefulness of programmed ventricular timulation in predicting future arrhythmic events in patients with cardiac sarcoidosis. Am J cardiol 2005;96:276-282
17. Kinney E, Murthy R,Ascuance G et al. Pericardial effusions in sarcoidosis. Chest 1979;76:476-478.
18. Hyodo E, Hozumi T, Takemoto Y et al. Early detection of cardiac involvement in patients with sarcoidosis by non invasive method with ultrasonic tissue charecterisation. Heart 2004;90:1275-1280
19. Smedema JP. Tissue Doppler imaging in cardiac sarcoidosis. Eur J Echocardiogr 2008;9:579-580
20. Tellier P, Paycha F, Antony I et al. Reversibility by dipyridamole of thallium 201 myocardial scan defects in patients with sarcoidosis. Am J Med 1988;85:189-193
21. Le Guludec D, Menad F, Faraggi M et al. Myocardial sarcoidosis. Clinical value of technetium-99m sestamibi tomoscintigraphy. Chest 1994;106:1675-1682.
22. Kinney EL, Jackson GL, Reeves WC et al. Thallium scan myocardial defects and echocardiographic abnormalities in patients with sarcoid osis without clinical cardiac dysfunction: an analysis of 44 patients. Am J Med 1980;68:497-503
23. Kinney EL, Cladwell JW. Do Thallium myocardial perfusion scan abnormalities predict survival in sarcoid patients without cardiac symptoms? Angiology 1990;41:573-576
24. Okamura W, Iwasaki T, Toyoma T et al. Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med 2004;45:1989-1998
25. Ishimaru S, Tsujino I, Takei T et al. Focal uptake on 18F- fluoro-2-deoxyglucose positron emission tomography images indiactes cardiac involvement of sarcoidosis. Eur Heart J. 2005;26:1538-43.
26. Yamagishi H, Shirai N, Takagi M et al. Identification of cardiac sarcoidosis with (13. NNH(3)/(18)F-FDG PET. J Nucl Med 2003;44;1030-1036.
27. Judson MA, Baughman RP, Teirstein AS et al. Defining organ involvement in sarcoidosis: the ACCESS Research group. A case control etiologic study of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:75-86.
28. Sharma S. Cardiac imaging in myocardial sarcoidosis and other cardiomyopathies. Curr Opin Pulm Med 2009; 15:507-512.
29. Vignaux O. Cardiac sarcoidosis: Spectrum of MRI features. AJR Am J Roentgenol 2005; 184:249-254.
30. Matsuki M, Matsuo M. MR findings in myocardial sarcoidosis. Clinical Radiology 2000;55:323-325.
31. Smedema JP, Snoep G, van kroonenburgh MP et al. Evaluation of accuracy of gadolinium enhanced cardiovascular magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis. J Am Coll Cardiol 2005;45:1683-1690.
32. Ohira H, Tsujino, Ishimaru S et al. Myocardial imaging with 18F-Fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging 2008;35:933-941.
33. Smedema JP, Snoep G, van kroonenburgh MP et al. Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centres in the Netherlands. Chest 2005;128:30-35.
34. Ichinose A, Otani H, Oikawa M et al. MRI of cardiac sarcoidosis: basal and subepicardial localization of myocardial lesions and their effect on left ventricular function. AJR Am J Roentgenol 2008;191:862-869.
35. Matoh F, Satoh H, Shiraki K et al. The usefulness of delayed enhancement magnetic resonance imaging for diagnosis and evaluation of cardiac function in patients with cardiac sarcoidosis. J Cardiol 2008;51:179-188.
36. Patel MR, Cawley PJ, Heitner JF et al. Detection of myocardial damage in patients with sarcoidosis. Circulation 2009;120:1969-1977
37. Adrehali H, Howard DL, Hariri A et al. A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initialy unexplained cardiomyopathy. Am Heart J 2005; 150:459-463.
38. Uemura GM, Hu W, Hare JM,et al. The spectrum of dilated cardiomyopathy - The Johns Hopkins experience with 1278 patients. Medicine (Baltimore) 1999;78:270-283
39. Yazaki Y, Isobe M, Hiore M et al. Central japan heart study group. prognostic determinants of long term survival in japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001;88:1006-1010.
40. Winers SL, Cohen M, Greenbrg S, et al. Sustained ventricular tachycardia associated with sarcoidosis: assessment of of underlying cardiac anatomy and the prospective utility of programmed ventricular stimulation, drug therapy,and an implantable anti tahycardia devise. J Am Coll cardiol 1991:18:937-943.
41. Jain A, Starek PJ, Delany DL, Ventricular tachycardia and ventriular aneurysm due to unrecognized sarcoidosis. Clin Cardiol 1990;13:738-740.
42. Harris IM, Duarino R. Cardiac Sarcoidosis: A new approach to treatment. Cardiovasc Surg. 1994;2:420-422.
43. Treba DO, Bensen MD, Assad LW. et al. Sarcoidosis and immunoglobulin lamda II light chain amyloidosis diagnosed after orthotropic heart transplantation. A case report and review of literature. Mod pathol 2005;18:451-455.
44. Stees C S, Khoo M S, Lowery C M, Sauer W H. Ventricular tachycardia storm successfully treated with immunosuppression and catheter ablation in a aptient with cardiac sarcoidosis. J cardiovasc Electrophysiol (Epub ahead of print)
45. Jefic D, Joel B, Good E, Morady F et al. Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: Report from a multicentre registry. Heart Rhythm 2009;6:189-195